obovatol has been researched along with 12-hydroxy-5,8,10,14-eicosatetraenoic acid in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jung, JK; Kim, TJ; Lee, JJ; Lee, MY; Ma, JY; Min, YK; Yu, JY; Yun, YP | 1 |
1 other study(ies) available for obovatol and 12-hydroxy-5,8,10,14-eicosatetraenoic acid
| Article | Year |
|---|---|
JJK694, a synthesized obovatol derivative, inhibits platelet activation by suppressing cyclooxygenase and lipoxygenase activities.
Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Animals; Biphenyl Compounds; Calcium; Catechols; Cell Survival; Cyclooxygenase Inhibitors; Cytosol; Dinoprostone; Lipoxygenase; Lipoxygenase Inhibitors; Male; Phenyl Ethers; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Prostaglandin-Endoperoxide Synthases; Rabbits; Serotonin | 2012 |